Navigation Links
Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies
Date:4/14/2008

ns."

Dr. Liang and her colleagues reported on their study of a bavituximab equivalent antibody, 2aG4, in combination with a clinical stage small molecule agent, PRIMA-1. PRIMA-1 restores the normal function of mutant forms of the tumor suppressor p53, enabling it to induce tumor cell death. The combination therapy resulted in additive and synergistic anti-tumor effects in two mouse models of advanced breast cancer, enhancing tumor regression and elimination, while also reducing the incidence of lymph node metastases in some subjects.

Dr. Liang noted, "These results indicate that PRIMA-1 plus 2aG4 combination therapy has a complementary and potent anti-tumor activity and could define a new strategy for suppression of advanced breast cancers."

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is usually located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab helps mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase lb pilot trial in advanced cancer patients, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. Peregrine has received regulatory approval to conduct three Phase II trials to study the anti-tumor effects of bavituximab in combination with chemotherapy. These include two breast cancer protocols and a non-small cell lung cancer protocol. One of the bavituximab breast cancer trials is currently enrolling and dosing patients and the two other trials are expected to begin shortly. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

No. 2341: Ya
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
11. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 In ... the Canadian International Pharmacy Association (CIPA) ... online from licensed Canadian pharmacies. Approximately 64% of respondents ... medications from a non-U.S. pharmacy due to costs ... not covered under their insurance plan.   ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Chief Operating Officer and Chief Financial Officer, will present at ... York City on Monday, June 1 at 8:30 ... and subsequently archived webcast of the presentation, go to the  ... http://investor.genomichealth.com .  Please connect to the web site at least ...
(Date:5/27/2015)... DUBLIN, Ohio , May 27, 2015 /PRNewswire/ ... present a new series of health economic outcomes ... evaluating real-world treatment patterns when developing value-based reimbursement ... , vice president and chief medical officer of ... and pharmaceutical companies alike have known for more ...
Breaking Medicine Technology:Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3
... Proportionality of,Company's Once-Daily Tramadol to be Published in ... - Labopharm Inc.,today announced that it will present ... formulation of tramadol at the 3rd,International Forum on ... July 1,2007 in Montreal, Canada. , The poster ...
... Advanced Life,Sciences Holdings, Inc. , today announced that it ... am (EDT) on Monday, July,2, 2007 to discuss data ... clinical trials designed to assess the safety and,effectiveness of ... acquired pneumonia (CAP). , Conference Call Details: , The ...
Cached Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Advanced Life Sciences to Host Conference Call to Discuss Data From,Cethromycin's First of Two Phase 3 Pneumonia Trials 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 Congratulations to ... Torch” Addiction Treatment Scholarship Award. From June 1, 2014 ... to 50 drug and alcohol addiction treatment centers around ... Scholarships were drawn at random at addiction treatment conferences ... Sky Toxicology, Matt Green said, “Sky Toxicology would like ...
(Date:5/27/2015)... National Harbor, MD (PRWEB) May 27, 2015 ... ) will attend this year’s conference of the American ... 17-20 at the Gaylord National Resort. MCA’s booth is ... Largest Annual Gathering in Immigration Law.” MCAads.com, a regular ... a family meeting” as they welcome current clients to ...
(Date:5/27/2015)... Widely regarded as being Arizona’s premier ... ages 18 to 40, Scottsdale Recovery Center announced ... Commission. The announcement follows SRC’s recent expansion ... a number of added clinical services, among which ... program in lieu of a growing national epidemic. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The Case ... its highest honor, the CMSA Lifetime Achievement Award, to ... ceremony on Thursday, June 25th at the association’s 25th ... in Orlando, Florida. , The CMSA Board of Directors ... who has made a significant contribution to practice of ...
(Date:5/27/2015)... TX (PRWEB) May 27, 2015 ... 2015” provides comprehensive information on the therapeutic development ... man has an orgasm sooner during intercourse. Premature ... report strengthens R&D pipelines by identifying new targets ... Complete report on H1 2015 pipeline review of ...
Breaking Medicine News(10 mins):Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:Arizona Drug Treatment Center SRC Announces JCAHO Accreditation 2Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Premature Ejaculation Therapeutic Development and Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... T-cell lymphoma became substantially more common in the United States ... the July issue of Archives of Dermatology. The rates of ... ,Cutaneous T-cell lymphoma occurs when certain cells of the ... skin. The term covers several types of lymphoma, according to ...
... to careers in medical research and teaching, new findings ... Women in Academic Medicine study* are published today at ... ,,Women doctors are strikingly under-represented in the university ... all 33 heads of UK medical schools are women, ...
... text your local hospital if you are about to ... today in Inderscience's International Journal of Electronic Healthcare. ... analyses them to produce an electrocardiogram (ECG) and sends ... text message. ,Cardiovascular disease is kills almost 20 ...
... that white bread and dig into that apple or lentils, ... latter that release energy slowly once they have been consumed ... spike blood sugar levels. ,Foods that release sugars ... those that release it slowly have a low glycaemic index, ...
... Holmes sparked of pregnancy rumours once again when she was ... the New York premiere of John Travolta starrer Hairspray dressed ... her bump, reports the Daily Mail. ,Holmes sparked ... their second child when she was spotted with bump while ...
... babies died at a government-run district hospital in Chhattisgarh ... state assembly Tuesday . ,Amid protests and allegations ... basic medical facilities at the hospital, Agrawal said the ... newly born babies in 2006 and 421 such deaths ...
Cached Medicine News:Health News:Cutaneous T-cell Lymphoma Shows Steady Increase 2Health News:Female Doctors Facing Barriers to Careers in Education and Research, Study Finds 2Health News:Probable Health Monitor Sends SMS of Emergency Alerts and ECG 2Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2
... F340 is a basic laboratory system for ... results can be obtained when used with ... electrode. • Fast and easy one and ... for five buffers (pH 1.68, 4.00, 7.00, ...
... The F340 is a basic laboratory ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... buffer recognition for five buffers (pH 1.68, ...
... high-end microplate reader with outstanding sensitivity and ... Fluorescence Intensity - FRET , Fluorescence Polarization ... , Luminescence , , , ... reader with fastest read times. The ultimate ...
... reader combines improved flexibility in ... a wide range of high-speed ... flexibility, sensitivity and high speed ... the ideal detection solution to ...
Medicine Products: